NCT04361292

Brief Summary

Intrauterine insemination (IUI) combined with ovarian stimulation, has been an extensively used procedure for the treatment of patients with unexplained infertility. The aim of this study was to report the effect of ejaculatory abstinence on sperm DNA fragmentation and pregnancy rates in IUI cycles, as well as the correlation between the two.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 29, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 22, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 24, 2020

Completed
Last Updated

April 27, 2020

Status Verified

April 1, 2020

Enrollment Period

12 months

First QC Date

April 22, 2020

Last Update Submit

April 23, 2020

Conditions

Keywords

Intrauterine inseminationEjaculatory abstinencesperm DNA fragmentationTUNEL assay

Outcome Measures

Primary Outcomes (1)

  • pregnancy rate

    The presence of one or more gestational sacs on transvaginal ultrasonography was described as clinical pregnancy.

    The pregnancy test was done 14 days after intrauterine insemination. If the test was positive, transvaginal ultrasonography was performed at 6-7 weeks of gestation.

Secondary Outcomes (1)

  • Sperm DNA fragmentation percentage

    On the day of IUI, semen samples were obtained and the sperm DNA fragmentation was measured by the TUNEL method in the inseminated sperm.

Study Arms (2)

Group A: one day abstinence period

ACTIVE COMPARATOR

Patients allocated into group A had an ejaculatory abstinence period of one day

Procedure: INTRAUTERINE INSEMINATION

Group B: three days abstinence period

ACTIVE COMPARATOR

Patients allocated into group B had an ejaculatory abstinence period of three days

Procedure: INTRAUTERINE INSEMINATION

Interventions

Intrauterine insemination (IUI) combined with ovarian stimulation, has been an extensively used procedure for the treatment of patients with unexplained infertility. The fact that IUI is less expensive, less invasive, and easier to perform than other assisted reproductive techniques makes it the first-line treatment option in infertility treatments. Sperm that have been washed and concentrated are placed directly into the uterus around the time of ovulation. All patients had ovulation induction with gonadotropins and ovulation was triggered by recombinant hcg.

Group A: one day abstinence periodGroup B: three days abstinence period

Eligibility Criteria

Age20 Years - 40 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsCouples with the diagnosis of unexplained infertility.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Infertility for more than 12 months
  • Diagnosed as unexplained infertility
  • Female age between 20 and 40 years
  • Regular menstrual cycles
  • Mid-luteal progesterone levels of \>3 ng/ml
  • Basal FSH \<12 mIU/ml, AMH \>1ng/ml
  • Body mass index (BMI) 19-35 kg/m2
  • No pelvic pathology documented by transvaginal ultrasound and bilateral tubal patency diagnosed by hysterosalpingography
  • Normal semen parameters according to WHO criteria

You may not qualify if:

  • Any endocrine and pelvic pathology
  • PCOS (polycystic ovarian syndrome)
  • Known endometriosis history
  • Prior pelvic surgery
  • Persistent ovarian cysts.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pamukkale University Faculty of Medicine, Obstetrics and Gynecology Department, Infertility Center

Denizli, Turkey (Türkiye)

Location

Related Publications (4)

  • Jurema MW, Vieira AD, Bankowski B, Petrella C, Zhao Y, Wallach E, Zacur H. Effect of ejaculatory abstinence period on the pregnancy rate after intrauterine insemination. Fertil Steril. 2005 Sep;84(3):678-81. doi: 10.1016/j.fertnstert.2005.03.044.

    PMID: 16169402BACKGROUND
  • Marshburn PB, Alanis M, Matthews ML, Usadi R, Papadakis MH, Kullstam S, Hurst BS. A short period of ejaculatory abstinence before intrauterine insemination is associated with higher pregnancy rates. Fertil Steril. 2010 Jan;93(1):286-8. doi: 10.1016/j.fertnstert.2009.07.972. Epub 2009 Sep 3.

    PMID: 19732887BACKGROUND
  • Thomson LK, Zieschang JA, Clark AM. Oxidative deoxyribonucleic acid damage in sperm has a negative impact on clinical pregnancy rate in intrauterine insemination but not intracytoplasmic sperm injection cycles. Fertil Steril. 2011 Oct;96(4):843-7. doi: 10.1016/j.fertnstert.2011.07.356. Epub 2011 Aug 11.

    PMID: 21839433BACKGROUND
  • Kabukcu C, Cil N, Cabus U, Alatas E. Effect of ejaculatory abstinence period on sperm DNA fragmentation and pregnancy outcome of intrauterine insemination cycles: A prospective randomized study. Arch Gynecol Obstet. 2021 Jan;303(1):269-278. doi: 10.1007/s00404-020-05783-0. Epub 2020 Sep 9.

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • CIHAN KABUKCU, M.D.

    Department of Obstetrics and Gynecology - Infertility Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
From the randomization list, an independent secretary who was blind to patients' identities applied the allocation in consecutive order. Patients allocated into group A, and group B. Care provider and investigator were blind to patient groups. Participants were informed about the timing of abstinence intervals, but they did not know which groups they were allocated to.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: One hundred twenty eligible couples were prospectively randomized into two groups on the second day of the cycle just before starting the treatment protocol. Randomization was performed according to a computer-generated random number list at a ratio of 1:1. From the randomization list, an independent secretary who was blind to patients' identities applied the allocation in consecutive order. Patients allocated into group A, had an ejaculatory abstinence period of one day, whereas patients allocated into group B had an ejaculatory abstinence period of three days.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, M.D.

Study Record Dates

First Submitted

April 22, 2020

First Posted

April 24, 2020

Study Start

January 1, 2019

Primary Completion

December 30, 2019

Study Completion

February 29, 2020

Last Updated

April 27, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations